Main Newsletter
Mastery Series
Therapy Series
 

Items for the Week

Ordered by most recent

Vitamin D and Type 2 Diabetes Risk

In an analysis using genetic data from over 25 different studies involving diabetes patients, researchers can find no causal association between higher vitamin D levels and lower diabetes risk...


Could a Lower Dose of Otelixizumab Preserve Beta-cell Function in Type 1?

Previous studies used higher doses of otelixizumab, an anti-CD3 monoclonal antibody, but also saw a reactivation of the Epstein Barr virus....


Longer Working Hours Associated with Higher Type 2 Incidence

Socioeconomic status plays a role in how strong the association is....



Gestational Weight Gain Associated with Infant Birth Weight in Type 1 Diabetes Mothers

Maternal weight gain is key to controlling infant birth weight....


Gastric Bypass Better than Gastric Band for Long-Term Results

Gastric bypass surgery shows better outcomes for long-term weight loss, controlling type 2 diabetes, hypertension, and cholesterol level....


Increased Risk of Childhood Obesity in Girls Exposed to Gestational Diabetes

Girls whose mothers were also overweight or obese had an even higher risk....


Adding an SGLT2 to Insulin Improved Control

Adding an SGLT2 inhibitor to multiple daily doses of insulin improved glycemic control, benefited weight loss, lowered insulin doses, and no increase in hypoglycemia was seen...


Healthy Lifestyle Lowers Risk for Gestational Diabetes by 52%

Adherence to healthy lifestyle during pregnancy is associated with a lower risk of gestational diabetes....


African-Americans More Likely to Have Amputations

Black Americans on Medicare are three times more likely than other patients to lose a leg to amputation because of complications with diabetes and peripheral arterial disease….


SGLT-2 Inhibitor May Reduce Blood Pressure for Type 2s

SGLT-2 inhibitor use in the management of glucose in type 2 diabetes could reduce blood pressure in patients with hypertension....


Potential of SGLT2 Inhibitors in Type 1 Diabetes

Pilot study shows that an SGLT-2 inhibitor doses of 5-mg and 10-mg were associated with significant reductions in blood glucose and total daily insulin dose....


"Millennial" Age Group Concerned about Managing Their Diabetes

However, older diabetes patients have a more serious attitude towards their disease....


Non-Caloric Artificial Sweeteners May Induce Glucose Intolerance

Consumption of non-caloric artificial sweeteners seems to induce glucose intolerance in mice and humans by altering gut microbiota.... 


HbA1c Testing Frequency Matters

Quarterly HbA1c testing associated with better glycemic control.... 


GLP-1 Receptor Agonist a Treatment Option in Type 2 Patients with Renal Insufficiency

Phase 3 trial demonstrates the safety and efficacy of albiglutide in type 2 diabetes patients with renal impairment.... 


Low Carb Diet Improves Quality of Life for Type 2 Diabetes Patients

Type 2 diabetes patients on a low-carb diet had improvements in physical function, pain reduction, and overall health after 12 months.... 


New GLP-1 Receptor Agonist as an Alternative to Insulin Glargine?

Dulaglutide shows efficacy in diabetes patients with poor glycemic control already taking multiple oral medications....


Two Positive Phase 3 Trials for ITCA 650 (Exenatide, a GLP-1 Agonist) in Type 2 Diabetes

FREEDOM-1 and FREEDOM-1 High Baseline (HBL) study showed positive results when added to standard oral diabetes medications.... 


Best Insulin Regimen for Type 1's

For people with type 1 diabetes, long-acting insulin may be a better treatment choice than intermediate-acting insulin....


Gout Linked to Increased Type 2 Diabetes Risk

Gout appears to increase the risk of type 2 diabetes, especially in women.... 


Study of Identical Twins Reveals Type 2 Diabetes Clues

By studying identical twins, researchers have identified mechanisms that could be behind the development of type 2 diabetes.... 


Post-surgery Complications More Likely with Insulin-dependent Diabetes

Insulin-dependent diabetes patients were at an increased risk of post-surgery complications following lumbar fusion including death, sepsis, wound infection and 30-day readmission....


Link between Lean BMI and Mortality in Diabetes

Type 2 diabetes patients with a BMI between 18.5 and 24.9 kg/m2 had the lowest mortality rate, while those in the 14.4 to 18.5 BMI range had an increased rate....


Tight Blood Sugar Control May Not Be Needed for Heart Bypass

Survival rates similar for those with looser glucose limits.... 


EASD: Insulin Pumps Lower Mortality Rate 29% Compared to Multiple Injections in T1DM

And fatal cardiovascular disease risk is 43% lower for type 1 diabetes patients using insulin pumps over multiple daily injections.... 


EASD: Targeting the Adaptive Glycosuria Response of SGLT2 Inhibitors Could Help Weight Loss

Combining SGLT2 inhibitor treatment with strategies to maintain energy intake or curb appetite could be an avenue for weight loss....


EASD: Probiotic Use and Islet Autoimmunity in Young Children

Early probiotic supplementation may reduce the risk of islet autoimmunity in young children....


EASD: Non-albuminuric CKD in Type 1 Diabetes Patients Increasing

Researchers are unsure why the phenotype is increasing but suggest that more effective treatments may be contributing to the increase in non-albuminuric...


EASD: Effects of Nitric Oxide on Insulin Clearance and Hepatic Lipid Metabolism

Higher levels of hypothalamic nitric oxide could lead to less insulin clearance and more lipogenesis....


EASD: Diabetic Peripheral Neuropathy and the Risk of Falling on Stairs

Patients with diabetic peripheral neuropathy (DPN) are more likely to experience a fall during stair walking.... 


EASD: Type 2 Diabetes plus Ischemic Heart Disease Can Predict Mortality

Long-term mortality of patients with ischemic heart disease is independently predicted by diabetes....


Exercise May Not Reduce Type 2 Diabetes Risk as Much in People with Increased Genetic Risk

"An interaction of genetic risk with physical activity on incident type 2 diabetes that appears to be driven principally through genetic risk to insulin resistance."... 


Liraglutide (Victoza) Provides Good Control with Less Hypoglycemia for MODY

Besides sulfonylureas, GLP-1RA can also be a treatment option for HNF1A diabetic patients....


No Mortality Reduction in Type 2 Diabetes with Tight Glycemic Control

No effect of tight glycemic control on mortality or major cardiovascular events in long-term follow-up of the ADVANCE trial.... 


Update: Islet Cell Transplantation for the Treatment of Type 1 Diabetes

Promising trial showed safe restoration of near-normoglycemia in type 1 diabetes....


Standing Desks Could Combat Childhood Obesity

Changing the type of desks students use in schools could impact the health of our nation....


FDA Approves Once-Weekly GLP-1 Diabetes Treatment Regimen for T2DM

Dulaglutide (Trulicity) is approved as a once-weekly injection for the treatment of type 2 diabetes....


No Risk Seen of CHF with Incretin-Based Drugs in T2DM

A large study in the UK looked at the long-term effects of GLP-1 and DPP-4 therapy on patients' risk of congestive heart failure....


Best Glycemic Control for T2DM Attained with GLP-1 Agonist + Insulin

Using a GLP-1 agonist with insulin may be the most effective therapy combination for lowering HbA1c in type 2 diabetes patients....


Effect of Low HDL Cholesterol on Cancer Risk in Type 2 Diabetes Patients

Low HDL increases the risk of heart disease but does it also increase the risk of cancer?...



Navigate through our listing of Items for the Week articles here.
Next Last

8935 Total articles for Items for the Week


Browse our other news categories below.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Looking for a particular Newsletter Issue? Click Here

2014 Most Popular Articles:

FDA Approves Once-Weekly GLP-1 Diabetes Treatment Regimen for T2DM
Posted September 25, 2014
Stanley Schwartz, MD: A New Way of Classifying Diabetes - The Beta-Cell Centric Approach
Posted September 29, 2014
Two Positive Phase 3 Trials for ITCA 650 (Exenatide, a GLP-1 Agonist) in Type 2 Diabetes
Posted October 10, 2014
Best Insulin Regimen for Type 1's
Posted October 10, 2014
EASD: Insulin Pumps Lower Mortality Rate 29% Compared to Multiple Injections in T1DM
Posted October 03, 2014
GLP-1 Agonist Medications Chart
Posted September 23, 2014
Non-Caloric Artificial Sweeteners May Induce Glucose Intolerance
Posted October 10, 2014
Handbook of Diabetes, 4th Ed., Excerpt #13: Control and Complications
Posted October 13, 2014
FDA Approves an Eye Drug for Diabetic Patients
Posted September 25, 2014
New GLP-1 Receptor Agonist as an Alternative to Insulin Glargine?
Posted October 10, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Do your teenage patients manage their diabetes well?
CME/CE of the Week
Wade Farrow, MD, CWS, FCCWS

Category: Vascular Therapy
Credits: 1


Advertisement


Search Articles On Diabetes In Control